The short-term effect of PRP on chronic pain in knee osteoarthritis

Objectives: The administration of platelet-rich plasma (PRP), which increases the release of growth factors targeting cartilage regeneration, is used in an effort to relieve pain in knee osteoarthritis (OA). This study measured the short-term efficacy of PRP on chronic pain in patients with OA of the knee. Methods: Patients with chronic knee pain and grade 2-4 knee OA based on the Kellgren-Lawrence (K-L) classification were enrolled in the study. A total of 60 knee joints of 42 patients who completed 3 doses of intraarticular PRP injections administered at intervals of 3 weeks were analyzed. The patients’ pain was evaluated using a resting and activity visual analog scale (VAS) on day 0, and at week 3, 6, and 12. Results: Of the 42 patients, 37 were female. The mean age and body mass index was 60.52±10.41 years and 28.5±9.71 kg/ m2. A total of 18 patients had bilateral knee involvement, and 39 of the 60 knee joints were classified as K-L grade 3-4 OA. A significant improvement was observed in the mean resting and activity VAS scores at day 0 and week 12 (p

Diz osteoartritinde PRP’nin kronik ağrı üzerine kısa dönem etkinliği

Amaç: Diz osteoartritinde (OA) kıkırdak rejenerasyonu sağlamaya yönelik büyüme faktörlerinin salınımını artıran platelet rich plasma (PRP) uygulamaları ile diz ağrılarında iyileşme sağlanmaya çalışılmaktadır. Biz de bu nedenle diz OA’da PRP’nin kronik ağrı üzerine kısa dönem etkinliğini ölçmeyi amaçladık. Gereç ve Yöntem: Kellgren – Lawrence (K-L) sınıflamasına göre grade 2-4 arası diz OA olan kronik diz ağrılı 69 hasta çalışmaya alındı. 3 hafta aralıklarla uygulanan 3 doz intraartiküler PRP enjeksiyonunu tamamlayan 42 hastanın 60 diz eklemi ile çalışma tamamlandı. Hastaların ağrıları 0. gün, 3., 6., ve 12. haftalarda istirahat ve aktivite visual analog scala (VAS) ile değerlendirildi. Bulgular: 37’si kadın 42 hastanın ortalama yaşı ve vücut kitle indeksi sırasıyla (ort±standart sapma (SS)) 60.52±10.41 ve 28.5±9.71 idi. Toplam 18 hasta bilateral diz olup, 60 diz ekleminin 39’u ise K-L grade 3-4 osteoartritti. Hastaların 0. gün ve 12. hafta ortalama istirahat ve aktivite VAS skorlarında; (sırasıyla (ort±SS), 5.13±2.70, 7.68±1.83 ve 2.60±2.05, 3.75±2.12, p

PDF

___

Kavadar G, Demircioglu DT, Celik MY, Emre TY. Effectiveness of platelet-rich plasma in the treatment of moderate knee osteoarthritis: a randomized prospective study. J Phys Ther Sci 2015;27(12):3863–7. [CrossRef]

Mangone G, Orioli A, Pinna A, Pasquetti P. Infiltrative treatment with Platelet Rich Plasma (PRP) in gonarthrosis. Clin Cases Miner Bone Metab 2014;11(1):67–72. [CrossRef]

Kim G, Kim E. Anti-inflammation effects of low intensity laser therapy on monosodium iodoacetate-induced osteoarthritis in rats. J Phys Ther Sci 2013;25:173–75. [CrossRef]

Chang KV, Hung CY, Aliwarga F, Wang TG, Han DS, Chen WS. Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: a systematic review and meta-analysis. Arch Phys Med Rehabil 2014;95(3):562–75. [CrossRef]

Cole BJ, Karas V, Hussey K, Pilz K, Fortier LA. Hyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-BlindRandomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis. Am J Sports Med 2017;45(2):339–46.

Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ 2004;328(7444):869. [CrossRef]

Jevsevar DS, Brown GA, Jones DL, Matzkin EG, Manner PA, Mooar P, et al. The American Academy of Orthopaedic Surgeons evidence-based guideline on: treatment of osteoarthritis of the knee, 2nd edition. J Bone Joint Surg Am 2013;95(20):1885–6. [CrossRef]

Hashemi M, Jalili P, Mennati S, Koosha A, Rohanifar R, Madadi F, et al. The Effects of Prolotherapy With Hypertonic Dextrose Versus Prolozone (Intraarticular Ozone) in Patients With Knee Osteoarthritis. Anesth Pain Med 2015;5:e27585.

Karan A, Müslümanoğlu L, Durmuş B, Ketenci A, Aydın R, Akı S, et al. Intraraticular Na-hyaluronate (Ortovisc) injection in knee osteoarthritis: comparison of different injection techniques and short term efficacy. Agri 2000;12(4):31–5.

Shen L, Yuan T, Chen S, Xie X, Zhang C. The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res 2017;12(1):16. [CrossRef]

Cugat R, Cuscó X, Seijas R, Álvarez P, Steinbacher G, Ares O, et al. Biologic enhancement of cartilage repair: the role of platelet-rich plasma and other commercially available growth factors. Arthroscopy 2015;31(4):777–83. [CrossRef]

Dragoo JL, Wasterlain AS, Braun HJ, Nead KT. Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial. Am J Sports Med 2014;42(3):610–8. [CrossRef]

Smyth NA, Murawski CD, Fortier LA, Cole BJ, Kennedy JG. Platelet-rich plasma in the pathologic processes of cartilage: review of basic science evidence. Arthroscopy 2013;29(8):1399–409. [CrossRef]

Hsu WK, Mishra A, Rodeo SR, Fu F, Terry MA, Randelli P, et al. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg 2013;21(12):739–48. [CrossRef]

Xie X, Zhang C, Tuan RS. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther 2014;16(1):204. [CrossRef]

Misso ML, Pitt VJ, Jones KM, Barnes HN, Piterman L, Green SE. Quality and consistency of clinical practice guidelines for diagnosis and management of osteoarthritis of the hip and knee: a descriptive overview of published guidelines. Med J Aust 2008;189(7):394–9.

Kijowski R, Blankenbaker D, Stanton P, Fine J, De Smet A. Arthroscopic validation of radiographic grading scales of osteoarthritis of the tibiofemoral joint. AJR Am J Roentgenol 2006;187(3):794–9. [CrossRef]

Dixon JS, Bird HA. Reproducibility along a 10 cm vertical visual analogue scale. Ann Rheum Dis 1981;40(1):87–9. [CrossRef]

Interventional procedure overview of platelet-rich plasma injections for osteoarthritis of the knee. NICE Interventional Procedure Guidance. Available at: https://www.nice.org. uk/guidance/ipg637/chapter/2-The-condition-currenttreatments-and-procedure. Accessed April 08, 2019.

Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 2001;10(4):225–8. [CrossRef]

Everts PA , Brown Mahoney C, Hoffmann JJ, Schönberger JP, Box HA, van Zundert A, et al. Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release. Growth Factors 2006;24(3):165–71. [CrossRef]

Lana JF, Weglein A, Sampson SE, Vicente EF, Huber SC, Souza CV, et al. Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee. J Stem Cells Regen Med 2016;12(2):69–78.

Kon E, Mandelbaum B, Buda R, Filardo G, Delcogliano M, Timoncini A, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 2011;27(11):1490–501. [CrossRef]

Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 2013;41(2):356–64.

Vaquerizo V, Plasencia MÁ, Arribas I, Seijas R, Padilla S, Orive G, et al. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. Arthroscopy 2013;29(10):1635–43. [CrossRef]

Marmotti A, Rossi R, Castoldi F, Roveda E, Michielon G, Peretti GM. PRP and articular cartilage: a clinical update. Biomed Res Int 2015;2015:542502. [CrossRef]

Calis HT, Sutbeyaz ST, Guler E, Halici C, Sayan H, Koc A, et al. Efficacy of intra-articular autologous platelet rich plasma application in knee osteoarthritis. Arch Rheumatol 2015;30:198–205. [CrossRef]

Castillo TN, Pouliot MA, Kim HJ, Dragoo JL. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med 2011;39(2):266–71. [CrossRef]

Filardo G, Kon E, Di Martino A, Di Matteo B, Merli ML, Cenacchi A, et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord 2012;13:229. [CrossRef]

Filardo G, Kon E, Buda R, Timoncini A, Di Martino A, Cenacchi A, et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2011;19(4):528–35. [CrossRef]